After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Abbvie Inc is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – General industry. The current market capitalization of Abbvie Inc is $336.64B. A total of 6.2 million shares were traded on the day, compared to an average of 6.90M shares.
In the most recent transaction, Stewart Jeffrey Ryan sold 58,832 shares of ABBV for 210.08 per share on Mar 31 ’25. After the transaction, the EVP, CHIEF COMMERCIAL OFFICER now owns 53,234 company shares. In a previous transaction on Mar 31 ’25, Stewart Jeffrey Ryan bought 58,832 shares at 210.09 per share.
Among the insiders who sold shares, Reents Scott T disposed of 17,644 shares on Mar 14 ’25 at a per-share price of $212.34. This resulted in the EVP, CHIEF FINANCIAL OFFICER holding 11,577 shares of ABBV after the transaction. In another insider transaction, Reents Scott T bought 17,644 shares at $212.35 per share on Mar 14 ’25.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Abbvie Inc pays an annual dividend of $6.47, resulting in a dividend yield of 3.39%, and it has a price to earnings (P/E) ratio of 81.26.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ABBV has a high of $218.66 and a low of $163.81.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ABBV’s latest balance sheet shows that the firm has $9.83B in Cash & Short Term Investments as of fiscal 2021. There were $76.68B in debt and $35.19B in liabilities at the time. Its Book Value Per Share was $0.80, while its Total Shareholder’s Equity was $15.44B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABBV is Buy with a score of 4.11.
